Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chang Sik Yu

Showing results (251-260 of 314) with videos related to

Pageof 32
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancerChang Sik Yu, Tae Won Kim, Jong Hoon Kim, et al.
Gastrointestinal Endoscopy|March 4, 2003
Clinicopathologic features of ileocolonic malignant lymphoma: analysis according to colonoscopic classificationSeung-Jae Myung, Kwang Ro Joo, Suk-Kyun Yang, et al.
Cancer|March 15, 2012
Can the new American Joint Committee on Cancer staging system predict survival in rectal cancer patients treated with curative surgery following preoperative chemoradiotherapy?Sang Hui Moon, Dae Yong Kim, Ji Won Park, et al.
Annals of Surgical Oncology|November 18, 2016
Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX)Jeong Eun Kim, Yong Sang Hong, Hwa Jung Kim, et al.
Oncology|February 14, 2012
Genetic polymorphisms of FcγRIIa and FcγRIIIa are not predictive of clinical outcomes after cetuximab plus irinotecan chemotherapy in patients with metastatic colorectal cancerSeong Joon Park, Yong Sang Hong, Jae-Lyun Lee, et al.
Cancer Science|June 18, 2011
Association between deficient mismatch repair system and efficacy to irinotecan-containing chemotherapy in metastatic colon cancerJeong Eun Kim, Yong Sang Hong, Min-Hee Ryu, et al.
Digestive Diseases and Sciences|March 19, 2017
Incidence of and Risk Factors for Free Bowel Perforation in Patients with Crohn's DiseaseJong Wook Kim, Ho-Su Lee, Byong Duk Ye, et al.
Annals of Surgical Treatment and Research|November 20, 2019
Hepatic resection after neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer: need for cautious planningYoung Il Kim, In Ja Park, Jeong Eun Kim, et al.
Journal of Clinical Gastroenterology|December 28, 2012
Long-term prognosis of the jejunal involvement of Crohn's diseaseSoo-Kyung Park, Suk-Kyun Yang, Seong Ho Park, et al.
Trials|January 20, 2016
The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: Study protocol for a randomized controlled trialChang Woo Kim, Jeong-Heum Baek, Gyu-Seog Choi, et al.
Pageof 32

Showing results (251-260 of 314) with videos related to

Sort By:
Pageof 32
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancerChang Sik Yu, Tae Won Kim, Jong Hoon Kim, et al.
Gastrointestinal Endoscopy|March 4, 2003
Clinicopathologic features of ileocolonic malignant lymphoma: analysis according to colonoscopic classificationSeung-Jae Myung, Kwang Ro Joo, Suk-Kyun Yang, et al.
Cancer|March 15, 2012
Can the new American Joint Committee on Cancer staging system predict survival in rectal cancer patients treated with curative surgery following preoperative chemoradiotherapy?Sang Hui Moon, Dae Yong Kim, Ji Won Park, et al.
Annals of Surgical Oncology|November 18, 2016
Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX)Jeong Eun Kim, Yong Sang Hong, Hwa Jung Kim, et al.
Oncology|February 14, 2012
Genetic polymorphisms of FcγRIIa and FcγRIIIa are not predictive of clinical outcomes after cetuximab plus irinotecan chemotherapy in patients with metastatic colorectal cancerSeong Joon Park, Yong Sang Hong, Jae-Lyun Lee, et al.
Cancer Science|June 18, 2011
Association between deficient mismatch repair system and efficacy to irinotecan-containing chemotherapy in metastatic colon cancerJeong Eun Kim, Yong Sang Hong, Min-Hee Ryu, et al.
Digestive Diseases and Sciences|March 19, 2017
Incidence of and Risk Factors for Free Bowel Perforation in Patients with Crohn's DiseaseJong Wook Kim, Ho-Su Lee, Byong Duk Ye, et al.
Annals of Surgical Treatment and Research|November 20, 2019
Hepatic resection after neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer: need for cautious planningYoung Il Kim, In Ja Park, Jeong Eun Kim, et al.
Journal of Clinical Gastroenterology|December 28, 2012
Long-term prognosis of the jejunal involvement of Crohn's diseaseSoo-Kyung Park, Suk-Kyun Yang, Seong Ho Park, et al.
Trials|January 20, 2016
The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: Study protocol for a randomized controlled trialChang Woo Kim, Jeong-Heum Baek, Gyu-Seog Choi, et al.
Pageof 32